Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Bullboard Posts
Post by Frictionon Sep 07, 2000 9:58pm
127 Views
Post# 2456325

repost

repostThis is a repost from sometime early in August. I never took the time to look, but I am sure there were dozens of posts complaining about late financials before the last time they were released. Some posters here said they called IR and were assured they would be released soon...blah blah blah...bashers showed up (ppatch) and everyone was worked up. RELAX!!!!!!! Everyone here says they are long, but can't wait for the next little morsal of news. Below is part of the old post: This is the way I see the next few weeks/months shaping up. jacqueline says sales are good. This shouldn't a surprize -- the sales momentim has been building for a while and i am guessing we are in the peak season for the industry. This should translate into black ink for the next financials The next financials should be released the last business day in Sept. The activity on this board will pick up, volume will pick up a bit, and people will get ansy in anticipation for the numbers just like they were last time. The first business day in October should see a nice bump. After the bump, there should be more headlines on SH, maybe a blurb from Bob Boaz (saying "I told you so"), and maybe the much awaited coverage by some bigger players. Aquisition: Who knows about this. I hold BRT.TO, have had it for some time. they did a private placement a while back for the purpose of an acquisition. It hasn't happened yet. So maybe it will be a while before something for COT unfolds. Be patient. Black ink will be enough to bouy this thing for a while (OT-- Brt.to helps B2B folks get up and running. They have had great growth, but the share price doesn't pop the way it used to. There will most likely be a shake out of the B2B players in the year to come. Hopefully Conac makes some good choices in that regard.) Late September and October look good. Keep the grumbling to a minimum until then. Friction
Bullboard Posts